chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pruritus, Pyrexia, Urticaria, Vaccination site erythema
Clinical narrative: hives itchy and scratchy; Fever; On the arm of Injection two circles, red circles; Hives; Asthma cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Asthma cough), PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0121220A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Drug allergy (Aspirin and Tylenol).    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced COUGH (Asthma cough). On 10-Jan-2021, the patient experienced PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives). At the time of the report, COUGH (Asthma cough), PRURITUS (hives itchy and scratchy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (On the arm of Injection two circles, red circles) and URTICARIA (Hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). On 21-Jan-2021, VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-11740 (E2B Linked Report).; Sender's Comments:  MOD21-11740:Crosslinked: Same reporter
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site lymphadenopathy, Vaccination site pain
Clinical narrative: area below injection side amost all the way to her elbow became red; lymph node below the arm was gettng bigger; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore), VACCINATION SITE ERYTHEMA (area below injection side amost all the way to her elbow became red) and VACCINATION SITE LYMPHADENOPATHY (lymph node below the arm was gettng bigger) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm was sore). On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (area below injection side amost all the way to her elbow became red) and VACCINATION SITE LYMPHADENOPATHY (lymph node below the arm was gettng bigger). The patient was treated with Manual therapy (Cold packs) for Vaccination site pain; Manual therapy (Cold packs) for Vaccination site erythema and Manual therapy (Cold packs) for Vaccination site lymphadenopathy. At the time of the report, VACCINATION SITE PAIN (arm was sore), VACCINATION SITE ERYTHEMA (area below injection side amost all the way to her elbow became red) and VACCINATION SITE LYMPHADENOPATHY (lymph node below the arm was gettng bigger) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Pruritus
Clinical narrative: armpit is very sore; armpit is super itchy; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy). At the time of the report, AXILLARY PAIN (armpit is very sore) and PRURITUS (armpit is super itchy) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Nasal congestion, Pyrexia
Clinical narrative: fell cold symptoms; running nose; pain in arm at injection site; felt feverish, slight temperature of 99; Headache; feeling tired; Sneezing; Nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (fell cold symptoms; running nose), VACCINATION SITE PAIN (pain in arm at injection site) and PYREXIA (felt feverish, slight temperature of 99) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy, Hypertension and High cholesterol. Concomitant products included METOPROLOL for Blood pressure high, CALCIUM for Calcium supplementation, ATORVASTATIN CALCIUM (ATORVASTATINE [ATORVASTATIN CALCIUM]) for High cholesterol, VITAMIN D3, PROBIOTICS NOS and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), VACCINATION SITE PAIN (pain in arm at injection site), PYREXIA (felt feverish, slight temperature of 99), HEADACHE (Headache) and FATIGUE (feeling tired). On 24-Jan-2021, the patient experienced RHINORRHOEA (fell cold symptoms; running nose). The patient was treated with PARACETAMOL (TYLENOL) 22-Jan-2021 for Headache, at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) 24-Jan-2021 for Runny nose, at a dose of 1 dosage form. On 28-Jan-2021, SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (fell cold symptoms; running nose), VACCINATION SITE PAIN (pain in arm at injection site), PYREXIA (felt feverish, slight temperature of 99), HEADACHE (Headache) and FATIGUE (feeling tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 99 (High) high.         This case was linked to MOD-2021-113500 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional info-1 :ADR form with updates to concomitant medications and medical history. More details about the events from dose 1
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing, Vaccination site pain
Clinical narrative: fell cold symptoms; running nose; pain in arm at injection site; felt feverish, slight temperature of 99; Headache; feeling tired; Sneezing; Nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (fell cold symptoms; running nose), VACCINATION SITE PAIN (pain in arm at injection site) and PYREXIA (felt feverish, slight temperature of 99) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy, Hypertension and High cholesterol. Concomitant products included METOPROLOL for Blood pressure high, CALCIUM for Calcium supplementation, ATORVASTATIN CALCIUM (ATORVASTATINE [ATORVASTATIN CALCIUM]) for High cholesterol, VITAMIN D3, PROBIOTICS NOS and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), VACCINATION SITE PAIN (pain in arm at injection site), PYREXIA (felt feverish, slight temperature of 99), HEADACHE (Headache) and FATIGUE (feeling tired). On 24-Jan-2021, the patient experienced RHINORRHOEA (fell cold symptoms; running nose). The patient was treated with PARACETAMOL (TYLENOL) 22-Jan-2021 for Headache, at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) 24-Jan-2021 for Runny nose, at a dose of 1 dosage form. On 28-Jan-2021, SNEEZING (Sneezing), NASAL CONGESTION (Nasal congestion), RHINORRHOEA (fell cold symptoms; running nose), VACCINATION SITE PAIN (pain in arm at injection site), PYREXIA (felt feverish, slight temperature of 99), HEADACHE (Headache) and FATIGUE (feeling tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 99 (High) high.         This case was linked to MOD-2021-113500 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional info-1 :ADR form with updates to concomitant medications and medical history. More details about the events from dose 1
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia
Clinical narrative: sore arm; little bit fever; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore arm) and PYREXIA (little bit fever) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ARTHRALGIA (sore arm) and PYREXIA (little bit fever). At the time of the report, ARTHRALGIA (sore arm) and PYREXIA (little bit fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: temperature of 102.4; Fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (Fatigue) and PYREXIA (temperature of 102.4) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 22-Jan-2021, the patient experienced FATIGUE (Fatigue). On 24-Jan-2021, the patient experienced PYREXIA (temperature of 102.4). At the time of the report, PAIN IN EXTREMITY (sore arm), FATIGUE (Fatigue) and PYREXIA (temperature of 102.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature:.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Productive cough, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Arm pain/Leg pain; Coughing up mucus; Arm was itching; arm Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain/Leg pain), PRODUCTIVE COUGH (Coughing up mucus), VACCINATION SITE PRURITUS (Arm was itching) and VACCINATION SITE PAIN (arm Pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain/Leg pain), PRODUCTIVE COUGH (Coughing up mucus), VACCINATION SITE PRURITUS (Arm was itching) and VACCINATION SITE PAIN (arm Pain). At the time of the report, PAIN IN EXTREMITY (Arm pain/Leg pain), PRODUCTIVE COUGH (Coughing up mucus) and VACCINATION SITE PAIN (arm Pain) outcome was unknown and VACCINATION SITE PRURITUS (Arm was itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter  No treatment was reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: Concomitant products included LEVOTHYROXINE and CELECOXIB (CELEBREX) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), RASH (rash only in her abdomen and back and lower part of the body) and PAIN (significant pain). At the time of the report, HERPES ZOSTER (shingles), RASH (rash only in her abdomen and back and lower part of the body) and PAIN (significant pain) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Vaccination site pain
Clinical narrative: lost appetite; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lost appetite) and VACCINATION SITE PAIN (Soreness in arm) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm). On 24-Jan-2021, the patient experienced DECREASED APPETITE (lost appetite). At the time of the report, DECREASED APPETITE (lost appetite) and VACCINATION SITE PAIN (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Patient denied to identify herself and refused further FU
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy
Clinical narrative: Lymph nodes swollen; Headache; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (Lymph nodes swollen) and HEADACHE (Headache) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0312H) for COVID-19 vaccination.     There was no medical history provided.  The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes swollen) and HEADACHE (Headache). At the time of the report, LYMPHADENOPATHY (Lymph nodes swollen) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Arm still very sore; hard knot under skin; wam to touch; red ring and red center; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm still very sore), VACCINATION SITE INDURATION (hard knot under skin), VACCINATION SITE WARMTH (wam to touch) and VACCINATION SITE ERYTHEMA (red ring and red center) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced MYALGIA (Arm still very sore), VACCINATION SITE INDURATION (hard knot under skin), VACCINATION SITE WARMTH (wam to touch) and VACCINATION SITE ERYTHEMA (red ring and red center). At the time of the report, MYALGIA (Arm still very sore), VACCINATION SITE INDURATION (hard knot under skin), VACCINATION SITE WARMTH (wam to touch) and VACCINATION SITE ERYTHEMA (red ring and red center) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: another dose 13 days after the first one; A spontaneous report, was received from a health care professional concerning a 88 year-old female patient, unknown race and ethnicity, who was administered two doses of Moderna's COVID-19 vaccine and experienced Inappropriate schedule of product administration.  The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided.  On 28 JAN 2021, the patient received their first planned dose of mRNA-1273 (batch number: 028L20A), intramuscularly for the prophylaxis of COVID-19 infection.  After 13 days on the day of 10 FEB 2021, the patient receive d second dose of mRNA-1273 (batch no : 010M20A) intramuscularly for the prophylaxis of COVID-19 infection.  No events or seriousness criteria is reported after the administration.  The health care professional wonders if they should administered a third dose on the right date or not.  Action taken for the vaccine mRNA -1273 was not applicable.  The outcome of the event, was considered as resolved on 10 FEB 2021.  Reporter's Comments: This case concerns a 88-year-old female patient who received their second of two planned doses of mRNA-1273 (Lot 010M20A), reporting Inappropriate schedule of product administration without any associated adverse events.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Red rash on arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Red rash on arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Penicillin allergy.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Red rash on arm). At the time of the report, VACCINATION SITE RASH (Red rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Condition aggravated, Diarrhoea, Fatigue, Flushing
Clinical narrative: stomach ache; diarrhea; felt flushed; weak and tired; Endometriosis started hurting really bad; left arm was very, very sore; This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired) and CONDITION AGGRAVATED (Endometriosis started hurting really bad) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired), CONDITION AGGRAVATED (Endometriosis started hurting really bad) and PAIN IN EXTREMITY (left arm was very, very sore). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired), CONDITION AGGRAVATED (Endometriosis started hurting really bad) and PAIN IN EXTREMITY (left arm was very, very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details Naproxym, Tylenol.  Upon internal review on 04-Aug-2021, the age was corrected to 39 years.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: stomach ache; diarrhea; felt flushed; weak and tired; Endometriosis started hurting really bad; left arm was very, very sore; This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired) and CONDITION AGGRAVATED (Endometriosis started hurting really bad) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired), CONDITION AGGRAVATED (Endometriosis started hurting really bad) and PAIN IN EXTREMITY (left arm was very, very sore). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), FLUSHING (felt flushed), FATIGUE (weak and tired), CONDITION AGGRAVATED (Endometriosis started hurting really bad) and PAIN IN EXTREMITY (left arm was very, very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details Naproxym, Tylenol.  Upon internal review on 04-Aug-2021, the age was corrected to 39 years.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: got really sick; discomfort in stomach; little bit sore; Feverish; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: got really sick; discomfort in stomach; little bit sore; Feverish; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish) and FATIGUE (Fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, VACCINATION COMPLICATION (got really sick), ABDOMINAL DISCOMFORT (discomfort in stomach), MYALGIA (little bit sore), PYREXIA (Feverish) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Skin rash - uncertain if vaccine related; This spontaneous case was reported by an other caregiver (subsequently medically confirmed) and describes the occurrence of RASH (Skin rash - uncertain if vaccine related) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Skin rash - uncertain if vaccine related). At the time of the report, RASH (Skin rash - uncertain if vaccine related) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Musculoskeletal chest pain
Clinical narrative: Rib Pain; tenderness of muscle under injected arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Rib Pain) and AXILLARY PAIN (tenderness of muscle under injected arm) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L201A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (Rib Pain) and AXILLARY PAIN (tenderness of muscle under injected arm). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Rib Pain) and AXILLARY PAIN (tenderness of muscle under injected arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bone pain, Malaise, Neuralgia
Clinical narrative: weakness; bone pain; nerve pain; feeling unwell; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), BONE PAIN (bone pain), NEURALGIA (nerve pain) and MALAISE (feeling unwell) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS. Concomitant products included GABAPENTIN, MELOXICAM (MOBIC), HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), TRAZODONE, METHOCARBAMOL, ZINC, CALCIUM and MAGNESIUM for an unknown indication.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced ASTHENIA (weakness), BONE PAIN (bone pain), NEURALGIA (nerve pain) and MALAISE (feeling unwell). At the time of the report, ASTHENIA (weakness), BONE PAIN (bone pain), NEURALGIA (nerve pain) and MALAISE (feeling unwell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included MULTI VITAMIN & MINERAL for an unknown indication There was no treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-up was received on 09-JUN-2021 Contains No new information. On 28-Jun-2021: Follow-up was received on 28-JUN-2021 contains No new information
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypersensitivity, SARS-CoV-2 test positive
Clinical narrative: Positive COVID Test; cough; Allergy symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID Test), HYPERSENSITIVITY (Allergy symptoms) and COUGH (cough) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced HYPERSENSITIVITY (Allergy symptoms). On 19-Jan-2021, the patient experienced COUGH (cough). On 20-Jan-2021, the patient experienced COVID-19 (Positive COVID Test). At the time of the report, COVID-19 (Positive COVID Test) and HYPERSENSITIVITY (Allergy symptoms) outcome was unknown and COUGH (cough) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, SARS-CoV-2 test positive: positive (Positive) Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow up received on 08-Jun-2021 Reporter Fax number updated.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Vomiting
Clinical narrative: Severe Headache; throwing up profusely; cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe Headache), VOMITING (throwing up profusely) and COUGH (cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (Severe Headache). On an unknown date, the patient experienced VOMITING (throwing up profusely) and COUGH (cough). At the time of the report, HEADACHE (Severe Headache), VOMITING (throwing up profusely) and COUGH (cough) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Skin reaction
Clinical narrative: Red, slightly raised itchy area around injection site; Delayed Reaction; red area around injection site; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE PRURITUS (Red, slightly raised itchy area around injection site), SKIN REACTION (Delayed Reaction) and INJECTION SITE ERYTHEMA (red area around injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20a) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced INJECTION SITE ERYTHEMA (red area around injection site). On 11-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Red, slightly raised itchy area around injection site) and SKIN REACTION (Delayed Reaction). At the time of the report, INJECTION SITE PRURITUS (Red, slightly raised itchy area around injection site), SKIN REACTION (Delayed Reaction) and INJECTION SITE ERYTHEMA (red area around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and PAIN (Body ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 120L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced PAIN (Body ache). At the time of the report, HEADACHE (headache) had not resolved and PAIN (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded. On 29-Apr-2021: Follow up information included additional event
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: Gland on the left side of the neck near the jaw became swollen; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Gland on the left side of the neck near the jaw became swollen) and VACCINATION SITE PAIN (tenderness at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026720A) for COVID-19 vaccination.     The patient's past medical history included Swollen glands.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced LYMPHADENOPATHY (Gland on the left side of the neck near the jaw became swollen) and VACCINATION SITE PAIN (tenderness at injection site). At the time of the report, LYMPHADENOPATHY (Gland on the left side of the neck near the jaw became swollen) and VACCINATION SITE PAIN (tenderness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications weren't reported Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up information included outcome of the events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in my ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in my ears) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in my ears). At the time of the report, TINNITUS (Ringing in my ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: vaginal spotting and bleeding; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (vaginal spotting and bleeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal spotting and bleeding). At the time of the report, VAGINAL HAEMORRHAGE (vaginal spotting and bleeding) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Redness in injection site; Itchiness in injection site; warm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness in injection site), VACCINATION SITE PRURITUS (Itchiness in injection site) and VACCINATION SITE WARMTH (warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness in injection site), VACCINATION SITE PRURITUS (Itchiness in injection site) and VACCINATION SITE WARMTH (warm). At the time of the report, VACCINATION SITE ERYTHEMA (Redness in injection site), VACCINATION SITE PRURITUS (Itchiness in injection site) and VACCINATION SITE WARMTH (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) and PRURITUS (Itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced URTICARIA (Hives) and PRURITUS (Itchy). At the time of the report, URTICARIA (Hives) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Swelling
Clinical narrative: Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone; Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone; Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone), PARAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone) and SWELLING (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced HYPOAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone), PARAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone) and SWELLING (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone). At the time of the report, HYPOAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone), PARAESTHESIA (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone) and SWELLING (Surface numbness, tingling, and swelling in neck and left side of face all the way up to cheek bone) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling
Clinical narrative: Arm was swollen; Red; Feels like heat is around the swollen part; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Red) and FEELING HOT (Feels like heat is around the swollen part) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L2OA) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Red) and FEELING HOT (Feels like heat is around the swollen part). At the time of the report, PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Red) and FEELING HOT (Feels like heat is around the swollen part) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chills, Dizziness, Fatigue
Clinical narrative: dizziness; body ache; fever; headache; chills; muscle ache; fatigue; blood pressure increased to 210/180; heat rate was 117; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN (body ache), BLOOD PRESSURE INCREASED (blood pressure increased to 210/180), HEART RATE INCREASED (heat rate was 117) and PYREXIA (fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure increased to 210/180) and HEART RATE INCREASED (heat rate was 117). On 21-Jan-2021, the patient experienced DIZZINESS (dizziness), PAIN (body ache), PYREXIA (fever), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle ache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), PAIN (body ache), BLOOD PRESSURE INCREASED (blood pressure increased to 210/180), PYREXIA (fever), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle ache) and FATIGUE (fatigue) had resolved and HEART RATE INCREASED (heat rate was 117) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Blood pressure measurement: 210/180. On 20-Jan-2021, Heart rate: 117.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Tylenol and Zyrtec
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Myalgia, Pain
Clinical narrative: dizziness; body ache; fever; headache; chills; muscle ache; fatigue; blood pressure increased to 210/180; heat rate was 117; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN (body ache), BLOOD PRESSURE INCREASED (blood pressure increased to 210/180), HEART RATE INCREASED (heat rate was 117) and PYREXIA (fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure increased to 210/180) and HEART RATE INCREASED (heat rate was 117). On 21-Jan-2021, the patient experienced DIZZINESS (dizziness), PAIN (body ache), PYREXIA (fever), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle ache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), PAIN (body ache), BLOOD PRESSURE INCREASED (blood pressure increased to 210/180), PYREXIA (fever), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle ache) and FATIGUE (fatigue) had resolved and HEART RATE INCREASED (heat rate was 117) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Blood pressure measurement: 210/180. On 20-Jan-2021, Heart rate: 117.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Tylenol and Zyrtec